Acura Pharmaceuticals Inc (NASDAQ:ACUR)

0.79
Delayed Data
As of Mar 30
 +0.04 / +5.33%
Today’s Change
0.41
Today|||52-Week Range
1.55
+75.56%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Acura Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 1.00 and a low estimate of 1.00. The median estimate represents a +26.58% increase from the last price of 0.79.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Acura Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.07
Sales
$7.6M
Reporting Date
Apr 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 216.67%
 
 
 
 
 
 
Growthannually 59.26%
 
 
 
 
 
 

Sales

Growthquarterly 1,335.92%
 
 
 
 
 
 
Growthannually 1,082.29%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account